Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcabene on Insulin Sensitivity in Nondiabetic Subjects
NCT02586168Phase 2Completed
- Sponsor
- NeuroBo Pharmaceuticals
- Start
- Jul 2001
- Primary completion
- Oct 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gemcabene in obesity, sponsored by NeuroBo Pharmaceuticals. Started Jul 2001; status: completed.
02
Drugs
gemcabene
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02586168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586168.